PTGER4 and neoplasm: Specific effects depending on the activation of the different EP receptor subtype have been described, including EP1-dependent tumor cell migration and invasion, EP2-induced angiogenesis and suppression of the anti-tumor immune response, and, finally, EP4-related tumor cell migration and metastasis.